The Biotech Growth Trust PLC
BIOG.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£82,516 | £74,600 | -£41,242 | -£202,270 |
| Dep. & Amort. | £0 | £0 | £0 | £0 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £0 | £0 | £0 | £0 |
| Change in WC | -£337 | £92 | -£88 | -£18,269 |
| Other Non-Cash | £77,766 | -£78,933 | £35,440 | £208,398 |
| Operating Cash Flow | -£5,087 | -£4,241 | -£5,890 | -£12,141 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | £0 | £0 | £0 | -£1,045 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | -£429,202 | -£350,835 | -£459,606 | -£440,205 |
| Inv. Sales/Matur. | £545,050 | £373,176 | £505,300 | £453,237 |
| Other Inv. Act. | £0 | £0 | £45,694 | -£1,045 |
| Investing Cash Flow | £115,848 | £22,341 | £45,694 | £13,032 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£48,484 | £26,287 | -£15,330 | £2,622 |
| Stock Issued | £0 | £0 | £0 | £2,097 |
| Stock Repurch. | -£54,483 | -£43,913 | -£20,910 | -£6,933 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£1,325 | -£1,115 | -£792 | -£179 |
| Financing Cash Flow | -£104,292 | -£18,741 | -£37,032 | -£2,393 |
| Forex Effect | -£147 | £0 | £0 | £0 |
| Net Chg. in Cash | £6,322 | -£641 | £2,772 | -£1,502 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £2,131 | £2,772 | £0 | £1,502 |
| End Cash | £8,453 | £2,131 | £2,772 | £0 |
| Free Cash Flow | -£5,087 | -£4,241 | -£5,890 | -£13,186 |